Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
John A Christopher
1
,
Sarah J Aves
1
,
Jason Brown
1
,
James C. Errey
1
,
Suki S Klair
2
,
C.J. Langmead
3
,
Oliver J Mace
1
,
Richard Mould
1
,
Jayesh C Patel
1
,
Benjamin G. Tehan
1
,
Andrei Zhukov
1
,
Fiona H. Marshall
1
,
Miles Congreve
1
1
Heptares Therapeutics Ltd., BioPark, Welwyn Garden City, Hertfordshire, U.K.
|
2
Labstract Ltd., Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire, U.K.
|
Тип публикации: Journal Article
Дата публикации: 2015-03-30
SJR: —
CiteScore: —
Impact factor: —
ISSN: 20402503, 20402511
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Pharmaceutical Science
Molecular Medicine
Краткое описание
A novel series of potent, selective, and orally efficacious dual antagonists of the orexin receptors is described.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
|
|
|
Journal of Medicinal Chemistry
2 публикации, 12.5%
|
|
|
Molecular Pharmacology
1 публикация, 6.25%
|
|
|
Nature Reviews Drug Discovery
1 публикация, 6.25%
|
|
|
Medicinal Chemistry Research
1 публикация, 6.25%
|
|
|
PLoS ONE
1 публикация, 6.25%
|
|
|
Current Opinion in Pharmacology
1 публикация, 6.25%
|
|
|
Advanced Synthesis and Catalysis
1 публикация, 6.25%
|
|
|
Annual Review of Pharmacology and Toxicology
1 публикация, 6.25%
|
|
|
ChemistrySelect
1 публикация, 6.25%
|
|
|
Journal of Organic Chemistry
1 публикация, 6.25%
|
|
|
Russian Chemical Reviews
1 публикация, 6.25%
|
|
|
Advanced Drug Delivery Reviews
1 публикация, 6.25%
|
|
|
1
2
|
Издатели
|
1
2
3
4
5
|
|
|
Elsevier
5 публикаций, 31.25%
|
|
|
American Chemical Society (ACS)
3 публикации, 18.75%
|
|
|
Springer Nature
2 публикации, 12.5%
|
|
|
Wiley
2 публикации, 12.5%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 публикация, 6.25%
|
|
|
Public Library of Science (PLoS)
1 публикация, 6.25%
|
|
|
Annual Reviews
1 публикация, 6.25%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 6.25%
|
|
|
1
2
3
4
5
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
16
Всего цитирований:
16
Цитирований c 2024:
3
(18.75%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Christopher J. A. et al. Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties // MedChemComm. 2015. Vol. 6. No. 5. pp. 947-955.
ГОСТ со всеми авторами (до 50)
Скопировать
Christopher J. A., Aves S. J., Brown J., Errey J. C., Klair S. S., Langmead C., Mace O. J., Mould R., Patel J. C., Tehan B. G., Zhukov A., Marshall F. H., Congreve M. Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties // MedChemComm. 2015. Vol. 6. No. 5. pp. 947-955.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1039/c5md00027k
UR - https://doi.org/10.1039/c5md00027k
TI - Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
T2 - MedChemComm
AU - Christopher, John A
AU - Aves, Sarah J
AU - Brown, Jason
AU - Errey, James C.
AU - Klair, Suki S
AU - Langmead, C.J.
AU - Mace, Oliver J
AU - Mould, Richard
AU - Patel, Jayesh C
AU - Tehan, Benjamin G.
AU - Zhukov, Andrei
AU - Marshall, Fiona H.
AU - Congreve, Miles
PY - 2015
DA - 2015/03/30
PB - Royal Society of Chemistry (RSC)
SP - 947-955
IS - 5
VL - 6
SN - 2040-2503
SN - 2040-2511
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2015_Christopher,
author = {John A Christopher and Sarah J Aves and Jason Brown and James C. Errey and Suki S Klair and C.J. Langmead and Oliver J Mace and Richard Mould and Jayesh C Patel and Benjamin G. Tehan and Andrei Zhukov and Fiona H. Marshall and Miles Congreve},
title = {Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties},
journal = {MedChemComm},
year = {2015},
volume = {6},
publisher = {Royal Society of Chemistry (RSC)},
month = {mar},
url = {https://doi.org/10.1039/c5md00027k},
number = {5},
pages = {947--955},
doi = {10.1039/c5md00027k}
}
Цитировать
MLA
Скопировать
Christopher, John A., et al. “Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties.” MedChemComm, vol. 6, no. 5, Mar. 2015, pp. 947-955. https://doi.org/10.1039/c5md00027k.
Профили